“…Compared with the BPSU study, in addition to the use of ECMO, adjunctive treatment was used more frequently in the patients in our study (clindamycin 56/62 (90%) vs 33/49 (67%), p=0.004; IVIG 30/62 (48%) vs 10/49 (20%), p=0.003) 8. Conversely, compared with our study, FFP was used more frequently in the patients in the BPSU study (15/62 (24%) vs 20/49 (40%), p=0.07) 8. FFP has substantially lower concentrations of antibodies compared with IVIG and has no proven anti-inflammatory effect.…”